高密度脂蛋白胆固醇,大小,颗粒数和强效他类药物治疗后的残留血管风险
Samia Mora1, Robert J Glynn, Paul M Ridker
1Center for Cardiovascular Disease Prevention, Division of Preventive Medicine (S.M., R.J.G., P.MR.) and Division of Cardiovascular Medicine (S.M., P.MR.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and Department of Biostatistics, Harvard School of Public Health, Boston, MA (R.J.G.).
Circulation
|September 5, 2013
概括
在接受他类药物治疗的患者中,高密度脂蛋白颗粒数 (HDL-P) 可能比HDL胆固醇 (HDL-C) 更好地预测心血管疾病风险. 这一发现表明,HDL-P可能是未来疗法更有效的点.
科学领域:
- 心血管医学 心血管医学
- 脂质代谢 脂质代谢是什么
- 药理学 药理学 是一个学科.
背景情况:
- 化学测量高密度脂蛋白胆固醇 (HDL-C) 可能不会准确地反映HDL的临床疗效.
- 在他类药物治疗期间,其他高密度胆固醇测量方法,如高密度胆固醇颗粒数 (HDL-P) 在残留心血管风险中的作用在很大程度上是未知的.
研究的目的:
- 为了调查HDL颗粒数 (HDL-P) 或HDL大小是否比HDL胆固醇 (HDL-C) 和阿波利波蛋白A-I (apoA-I) 更好地预测残留心血管疾病 (CVD) 风险.
- 评估罗斯瓦斯塔丁对各种高血压水平参数的影响.
主要方法:
- 来自"预防中使用他类药物的理由:评估罗斯瓦斯塔丁的干预试验" (JUPITER) 研究的数据分析.
- 使用核磁共振光谱学测量HDL大小和HDL-P.
- 在10886名参与者接受罗斯瓦斯塔丁治疗前后的HDL-C和阿波利波蛋白AI (apoA-I) 的化学测定.
主要成果:
- HDL-P与apoA-I的相关性比HDL-C更强.
- 罗斯瓦斯塔丁显著降低了LDL-C,并增加了HDL-C,apoA-I,HDL-P和HDL大小.
- 在治疗期间,HDL-P在接受罗斯瓦斯塔丁治疗的患者中显示出与心血管疾病风险的显著反向关联,即使对HDL-C进行调整后,这种关联仍然显著.
结论:
- 在接受强效他类药物治疗的患者中,高密度胆固醇颗粒数 (HDL-P) 与高密度胆固醇-C和apoA-I相比,可以作为残留心血管风险的优异标记.
- 这些发现对开发针对高密度胆固醇代谢和功能的新疗法有影响.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
